Repression of lung tumor suppressor gene G protein-coupled receptor class C group 5 member A expression by inflammatory signal pathway
10.3969/j.issn.1674-8115.2018.05.001
- Author:
Dong-Liang XU
1
Author Information
1. Department of Pathophysiology, Shanghai Jiao Tong University College of Basic Medical Sciences
- Publication Type:Journal Article
- Keywords:
G protein-coupled receptor class C group 5 member A (GPRC5A);
Inflammation;
Lung tumor;
Nuclear factor κB (NF-κB);
Tumor necrosis factor α (TNF-α)
- From:
Journal of Shanghai Jiaotong University(Medical Science)
2018;38(5):487-492
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the regulatory effects of inflammatory signaling pathway on the expression of G protein-coupled receptor class C group 5 member A (GPRC5A). Methods: Nuclear factor κB (NF-κB)-driven luciferase mice were intraperitoneally injected with lipopolysaccharide (LPS) to evaluate the activation of NF-κB in lungs. GPRC5A expression in lungs was assessed by Western blotting in the C57BL/6J mice injected with LPS. In vitro tests, human lung tumor cell lines Calu-1 and H322, and human embryonic kidney cell line HEK293T were administered with tumor necrosis factor α (TNF-α) or transfected with p65 expression plasmid; Western blotting, RT-PCR, luciferase reporter gene experiment and immunofluorescence assay were used to analyze the effect of inflammation on GPRC5A expression. Results: Intraperitoneal injection of LPS induced activation of NF-κB pathway in lung tissues, which suppressed the expression of GPRC5A in mice lungs. In Calu-1 cells, TNF-α treatment greatly suppressed the expression of GPRC5A protein and mRNA. In HEK293T cells, transfection of p65 subunit of NF-κB suppressed the expression of GPRC5A promoter-driven luciferase reporter. The H322 cells transfected with green fluorescent protein-p65 almost did not express GPRC5A. Conclusion: NF-κB pathway acts at the promoter of GPRC5A and suppresses its mRNA and protein expression.
